C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01) A61K 31/495 (2006.01) A61P 11/00 (2006.01) A61P 29/00 (2006.01) C07D 473/00 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2607929
The use of a compound of formula (I): for the manufacture of a medicament for the treatment of conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1, also known as TRPV1).
Utilisation d'un composé de formule (I): pour la fabrication d'un médicament pour le traitement d'états améliorés par la modulation de la fonction du récepteur vanilloïde-1 (VR1, aussi connu sous le nom de TRPV1).
Bakthalvatchalam Rajagopal
Bayliss Tracey
Blum Charles A.
Brown Rebecca Elizabeth
Capitosti Scott
Merck Sharp & Dohme Limited
Neurogen Corporation
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
2,3-substituted fused bicyclic pyrimidin-4(3h)-ones... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1762055